Hayashida Jon K.
VP, Global Clinical, Medical at STAA
- Sold, on record
- $10.7M
- Dollars the filings state
- Form 4 sales
- 8
- Latest May 10, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- STAASTAAR SURGICAL COVP, Global Clinical, Medical
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale STAAUnusualDec 5 2019
Sold 47,408 shares at $37.20 ($1.8M)
Hayashida Jon K., VP, Global Clinical, Medical
Sold 88.4% of holdings ($2M position)6,250 shares leftFirst sale on recordFiling
- 2 Form 4 sale STAAPlan not statedMar 23 +109 days
Sold 2,813 shares at $26.83 ($75k)
Hayashida Jon K., VP, Global Clinical, Medical
Sold 20.7% of holdings ($365k position)10,794 shares leftFiling
- 3 Form 4 sale STAAUnusualMay 11 +49 days
Sold 46,563 shares at $39.11 ($1.8M)
Hayashida Jon K., VP, Global Clinical, Medical
Sold 81.2% of holdings ($2.2M position)10,794 shares leftFiling
- 4 Form 4 sale STAAUnusualAug 10 +91 days
Sold 41,602 shares at $51.22 ($2.1M)
Hayashida Jon K., VP, Global Clinical, Medical
Sold 79.4% of holdings ($2.7M position)10,794 shares left0.9x usual sizeFiling
- 5 Form 4 sale STAAUnusualNov 9 +91 days
Sold 20,000 shares at $81.34 ($1.6M)
Hayashida Jon K., VP, Global Clinical, Medical
Sold 64.9% of holdings ($2.5M position)10,794 shares left0.5x usual sizeFiling
- 6 Form 4 sale STAAUnusualMar 1 +112 days
Sold 16,000 shares at $105.43 ($1.7M)
Hayashida Jon K., VP, Global Clinical, Medical
Sold 59.7% of holdings ($2.8M position)10,794 shares left0.4x usual sizeFiling
- 7 Form 4 sale STAAPlan not statedMar 22 +21 days
Sold 1,103 shares at $96.37 ($106k)
Hayashida Jon K., VP, Global Clinical, Medical
Sold 10.2% of holdings ($1M position)9,691 shares left0x usual sizeFiling
- 8 Form 4 sale STAAUnusualMay 10 +49 days
Sold 12,109 shares at $124.25 ($1.5M)
Hayashida Jon K., VP, Global Clinical, Medical
Sold 42.6% of holdings ($3.5M position)16,301 shares left0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 10, 2021 | STAA | VP, Global Clinical, Medical | Form 4 sale | 12,109 | $1.5M | 42.6% | Unusual | SEC |
| Mar 22, 2021 | STAA | VP, Global Clinical, Medical | Form 4 sale | 1,103 | $106k | 10.2% | Plan not stated | SEC |
| Mar 1, 2021 | STAA | VP, Global Clinical, Medical | Form 4 sale | 16,000 | $1.7M | 59.7% | Unusual | SEC |
| Nov 9, 2020 | STAA | VP, Global Clinical, Medical | Form 4 sale | 20,000 | $1.6M | 64.9% | Unusual | SEC |
| Aug 10, 2020 | STAA | VP, Global Clinical, Medical | Form 4 sale | 41,602 | $2.1M | 79.4% | Unusual | SEC |
| May 11, 2020 | STAA | VP, Global Clinical, Medical | Form 4 sale | 46,563 | $1.8M | 81.2% | Unusual | SEC |
| Mar 23, 2020 | STAA | VP, Global Clinical, Medical | Form 4 sale | 2,813 | $75k | 20.7% | Plan not stated | SEC |
| Dec 5, 2019 | STAA | VP, Global Clinical, Medical | Form 4 sale | 47,408 | $1.8M | 88.4% | Unusual | SEC |